Published online 27 January 2003 doi:10.1084/jem.20021652
© Rockefeller University Press,
0022-1007/2003/2/343 $5.00
The Journal of Experimental Medicine, Volume 197, Number 3, 343-351
The Poxvirus Protein A52R Targets Toll-like Receptor Signaling Complexes to Suppress Host Defense
Mary T. Harte1,
Ismar R. Haga3,
Geraldine Maloney2,
Pearl Gray1,
Patrick C. Reading3,
Nathan W. Bartlett3,
Geoffrey L. Smith3,
Andrew Bowie2 and
Luke A.J. O'Neill1
1 The Cytokine Research Group, Department of Biochemistry, Trinity College, Dublin 2, Ireland
2 The Viral Immune Evasion Group, Department of Biochemistry, Trinity College, Dublin 2, Ireland
3 Department of Virology, The Wright-Fleming Institute, Faculty of Medicine, Imperial College of Science, Technology & Medicine, St. Mary's Campus, London W2 1PG, United Kingdom
Address correspondence to Andrew Bowie, Department of Biochemistry, Trinity College, Dublin 2, Ireland. Phone: 353-1-6082435; Fax: 353-1-6772400; E-mail: agbowie{at}tcd.ie
Toll-like receptors (TLRs) are crucial in the innate immune response to pathogens, in that they recognize and respond to pathogen associated molecular patterns, which leads to activation of intracellular signaling pathways and altered gene expression. Vaccinia virus (VV), the poxvirus used to vaccinate against smallpox, encodes proteins that antagonize important components of host antiviral defense. Here we show that the VV protein A52R blocks the activation of the transcription factor nuclear factor
B (NF-
B) by multiple TLRs, including TLR3, a recently identified receptor for viral RNA. A52R associates with both interleukin 1 receptorassociated kinase 2 (IRAK2) and tumor necrosis factor receptorassociated factor 6 (TRAF6), two key proteins important in TLR signal transduction. Further, A52R could disrupt signaling complexes containing these proteins. A virus deletion mutant lacking the A52R gene was attenuated compared with wild-type and revertant controls in a murine intranasal model of infection. This study reveals a novel mechanism used by VV to suppress the host immunity. We demonstrate viral disabling of TLRs, providing further evidence for an important role for this family of receptors in the antiviral response.
Key Words: nuclear factor
B signal transduction vaccinia virus immunomodulation Toll-like receptor

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Wang, F., Barrett, J. W., Ma, Y., Dekaban, G. A., McFadden, G.
(2009). Induction of Alpha/Beta Interferon by Myxoma Virus Is Selectively Abrogated When Primary Mouse Embryo Fibroblasts Become Immortalized. J. Virol.
83: 5928-5932
[Abstract]
[Full Text]
-
Zhao, Y., De Trez, C., Flynn, R., Ware, C. F., Croft, M., Salek-Ardakani, S.
(2009). The Adaptor Molecule MyD88 Directly Promotes CD8 T Cell Responses to Vaccinia Virus. J. Immunol.
182: 6278-6286
[Abstract]
[Full Text]
-
Chang, S.-J., Hsiao, J.-C., Sonnberg, S., Chiang, C.-T., Yang, M.-H., Tzou, D.-L., Mercer, A. A., Chang, W.
(2009). Poxvirus Host Range Protein CP77 Contains an F-Box-Like Domain That Is Necessary To Suppress NF-{kappa}B Activation by Tumor Necrosis Factor Alpha but Is Independent of Its Host Range Function. J. Virol.
83: 4140-4152
[Abstract]
[Full Text]
-
Lehmann, M. H., Kastenmuller, W., Kandemir, J. D., Brandt, F., Suezer, Y., Sutter, G.
(2009). Modified Vaccinia Virus Ankara Triggers Chemotaxis of Monocytes and Early Respiratory Immigration of Leukocytes by Induction of CCL2 Expression. J. Virol.
83: 2540-2552
[Abstract]
[Full Text]
-
Fahy, A. S., Clark, R. H., Glyde, E. F., Smith, G. L.
(2008). Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence. J. Gen. Virol.
89: 2377-2387
[Abstract]
[Full Text]
-
Randall, R. E., Goodbourn, S.
(2008). Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol.
89: 1-47
[Abstract]
[Full Text]
-
Vercammen, E., Staal, J., Beyaert, R.
(2008). Sensing of Viral Infection and Activation of Innate Immunity by Toll-Like Receptor 3. Clin. Microbiol. Rev.
21: 13-25
[Abstract]
[Full Text]
-
Hutchens, M., Luker, K. E., Sottile, P., Sonstein, J., Lukacs, N. W., Nunez, G., Curtis, J. L., Luker, G. D.
(2008). TLR3 Increases Disease Morbidity and Mortality from Vaccinia Infection. J. Immunol.
180: 483-491
[Abstract]
[Full Text]
-
Keating, S. E., Maloney, G. M., Moran, E. M., Bowie, A. G.
(2007). IRAK-2 Participates in Multiple Toll-like Receptor Signaling Pathways to NF{kappa}B via Activation of TRAF6 Ubiquitination. J. Biol. Chem.
282: 33435-33443
[Abstract]
[Full Text]
-
Waibler, Z., Anzaghe, M., Ludwig, H., Akira, S., Weiss, S., Sutter, G., Kalinke, U.
(2007). Modified Vaccinia Virus Ankara Induces Toll-Like Receptor-Independent Type I Interferon Responses. J. Virol.
81: 12102-12110
[Abstract]
[Full Text]
-
Marshall-Clarke, S., Downes, J. E., Haga, I. R., Bowie, A. G., Borrow, P., Pennock, J. L., Grencis, R. K., Rothwell, P.
(2007). Polyinosinic Acid Is a Ligand for Toll-like Receptor 3. J. Biol. Chem.
282: 24759-24766
[Abstract]
[Full Text]
-
Guerra, S., Najera, J. L., Gonzalez, J. M., Lopez-Fernandez, L. A., Climent, N., Gatell, J. M., Gallart, T., Esteban, M.
(2007). Distinct Gene Expression Profiling after Infection of Immature Human Monocyte-Derived Dendritic Cells by the Attenuated Poxvirus Vectors MVA and NYVAC. J. Virol.
81: 8707-8721
[Abstract]
[Full Text]
-
Leppert, B. J., Mansfield, J. M., Paulnock, D. M.
(2007). The Soluble Variant Surface Glycoprotein of African Trypanosomes Is Recognized by a Macrophage Scavenger Receptor and Induces I{kappa}B{alpha} Degradation Independently of TRAF6-Mediated TLR Signaling. J. Immunol.
179: 548-556
[Abstract]
[Full Text]
-
Wong, R. T.-Y., Hon, C.-C., Zeng, F., Leung, F. C.-C.
(2007). Screening of differentially expressed transcripts in infectious bursal disease virus-induced apoptotic chicken embryonic fibroblasts by using cDNA microarrays. J. Gen. Virol.
88: 1785-1796
[Abstract]
[Full Text]
-
Jing, L., Chong, T. M., Byrd, B., McClurkan, C. L., Huang, J., Story, B. T., Dunkley, K. M., Aldaz-Carroll, L., Eisenberg, R. J., Cohen, G. H., Kwok, W. W., Sette, A., Koelle, D. M.
(2007). Dominance and Diversity in the Primary Human CD4 T Cell Response to Replication-Competent Vaccinia Virus. J. Immunol.
178: 6374-6386
[Abstract]
[Full Text]
-
Yonkers, N. L., Rodriguez, B., Milkovich, K. A., Asaad, R., Lederman, M. M., Heeger, P. S., Anthony, D. D.
(2007). TLR Ligand-Dependent Activation of Naive CD4 T Cells by Plasmacytoid Dendritic Cells Is Impaired in Hepatitis C Virus Infection. J. Immunol.
178: 4436-4444
[Abstract]
[Full Text]
-
Gowen, B. B., Hoopes, J. D., Wong, M.-H., Jung, K.-H., Isakson, K. C., Alexopoulou, L., Flavell, R. A., Sidwell, R. W.
(2006). TLR3 Deletion Limits Mortality and Disease Severity due to Phlebovirus Infection. J. Immunol.
177: 6301-6307
[Abstract]
[Full Text]
-
Deng, L., Dai, P., Ding, W., Granstein, R. D., Shuman, S.
(2006). Vaccinia virus infection attenuates innate immune responses and antigen presentation by epidermal dendritic cells.. J. Virol.
80: 9977-9987
[Abstract]
[Full Text]
-
Gedey, R., Jin, X.-L., Hinthong, O., Shisler, J. L.
(2006). Poxviral Regulation of the Host NF-{kappa}B Response: the Vaccinia Virus M2L Protein Inhibits Induction of NF-{kappa}B Activation via an ERK2 Pathway in Virus-Infected Human Embryonic Kidney Cells.. J. Virol.
80: 8676-8685
[Abstract]
[Full Text]
-
Riordan, S. M., Skinner, N., Kurtovic, J., Locarnini, S., Visvanathan, K.
(2006). Reduced expression of toll-like receptor 2 on peripheral monocytes in patients with chronic hepatitis B.. CVI
13: 972-974
[Abstract]
[Full Text]
-
Tscharke, D. C., Woo, W.-P., Sakala, I. G., Sidney, J., Sette, A., Moss, D. J., Bennink, J. R., Karupiah, G., Yewdell, J. W.
(2006). Poxvirus CD8+ T-Cell Determinants and Cross-Reactivity in BALB/c Mice.. J. Virol.
80: 6318-6323
[Abstract]
[Full Text]
-
Beard, P. M., Froggatt, G. C., Smith, G. L.
(2006). Vaccinia virus kelch protein A55 is a 64 kDa intracellular factor that affects virus-induced cytopathic effect and the outcome of infection in a murine intradermal model. J. Gen. Virol.
87: 1521-1529
[Abstract]
[Full Text]
-
Boughan, P. K., Argent, R. H., Body-Malapel, M., Park, J.-H., Ewings, K. E., Bowie, A. G., Ong, S. J., Cook, S. J., Sorensen, O. E., Manzo, B. A., Inohara, N., Klein, N. J., Nunez, G., Atherton, J. C., Bajaj-Elliott, M.
(2006). Nucleotide-binding Oligomerization Domain-1 and Epidermal Growth Factor Receptor: CRITICAL REGULATORS OF beta-DEFENSINS DURING HELICOBACTER PYLORI INFECTION. J. Biol. Chem.
281: 11637-11648
[Abstract]
[Full Text]
-
Rudd, B. D., Smit, J. J., Flavell, R. A., Alexopoulou, L., Schaller, M. A., Gruber, A., Berlin, A. A., Lukacs, N. W.
(2006). Deletion of TLR3 Alters the Pulmonary Immune Environment and Mucus Production during Respiratory Syncytial Virus Infection. J. Immunol.
176: 1937-1942
[Abstract]
[Full Text]
-
Nichols, D. B., Shisler, J. L.
(2006). The MC160 Protein Expressed by the Dermatotropic Poxvirus Molluscum Contagiosum Virus Prevents Tumor Necrosis Factor Alpha-Induced NF-{kappa}B Activation via Inhibition of I Kappa Kinase Complex Formation. J. Virol.
80: 578-586
[Abstract]
[Full Text]
-
Carroll, T. P., Greene, C. M., Taggart, C. C., Bowie, A. G., O'Neill, S. J., McElvaney, N. G.
(2005). Viral Inhibition of IL-1- and Neutrophil Elastase-Induced Inflammatory Responses in Bronchial Epithelial Cells. J. Immunol.
175: 7594-7601
[Abstract]
[Full Text]
-
Li, P., Wang, N., Zhou, D., Yee, C. S. K., Chang, C.-H., Brutkiewicz, R. R., Blum, J. S.
(2005). Disruption of MHC Class II-Restricted Antigen Presentation by Vaccinia Virus. J. Immunol.
175: 6481-6488
[Abstract]
[Full Text]
-
Melchjorsen, J., Jensen, S. B., Malmgaard, L., Rasmussen, S. B., Weber, F., Bowie, A. G., Matikainen, S., Paludan, S. R.
(2005). Activation of Innate Defense against a Paramyxovirus Is Mediated by RIG-I and TLR7 and TLR8 in a Cell-Type-Specific Manner. J. Virol.
79: 12944-12951
[Abstract]
[Full Text]
-
Esteban, D. J., Buller, R. M. L.
(2005). Ectromelia virus: the causative agent of mousepox. J. Gen. Virol.
86: 2645-2659
[Abstract]
[Full Text]
-
Maloney, G., Schroder, M., Bowie, A. G.
(2005). Vaccinia Virus Protein A52R Activates p38 Mitogen-activated Protein Kinase and Potentiates Lipopolysaccharide-induced Interleukin-10. J. Biol. Chem.
280: 30838-30844
[Abstract]
[Full Text]
-
Isogawa, M., Robek, M. D., Furuichi, Y., Chisari, F. V.
(2005). Toll-Like Receptor Signaling Inhibits Hepatitis B Virus Replication In Vivo. J. Virol.
79: 7269-7272
[Abstract]
[Full Text]
-
Shaw, M. L., Cardenas, W. B., Zamarin, D., Palese, P., Basler, C. F.
(2005). Nuclear Localization of the Nipah Virus W Protein Allows for Inhibition of both Virus- and Toll-Like Receptor 3-Triggered Signaling Pathways. J. Virol.
79: 6078-6088
[Abstract]
[Full Text]
-
Stack, J., Haga, I. R., Schroder, M., Bartlett, N. W., Maloney, G., Reading, P. C., Fitzgerald, K. A., Smith, G. L., Bowie, A. G.
(2005). Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence. JEM
201: 1007-1018
[Abstract]
[Full Text]
-
McCoy, S. L., Kurtz, S. E., MacArthur, C. J., Trune, D. R., Hefeneider, S. H.
(2005). Identification of a Peptide Derived from Vaccinia Virus A52R Protein That Inhibits Cytokine Secretion in Response to TLR-Dependent Signaling and Reduces In Vivo Bacterial-Induced Inflammation. J. Immunol.
174: 3006-3014
[Abstract]
[Full Text]
-
Li, K., Foy, E., Ferreon, J. C., Nakamura, M., Ferreon, A. C. M., Ikeda, M., Ray, S. C., Gale, M. Jr., Lemon, S. M.
(2005). Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc. Natl. Acad. Sci. USA
102: 2992-2997
[Abstract]
[Full Text]
-
Afonso, C. L., Delhon, G., Tulman, E. R., Lu, Z., Zsak, A., Becerra, V. M., Zsak, L., Kutish, G. F., Rock, D. L.
(2005). Genome of Deerpox Virus. J. Virol.
79: 966-977
[Abstract]
[Full Text]
-
Zipris, D., Lien, E., Xie, J. X., Greiner, D. L., Mordes, J. P., Rossini, A. A.
(2005). TLR Activation Synergizes with Kilham Rat Virus Infection to Induce Diabetes in BBDR Rats. J. Immunol.
174: 131-142
[Abstract]
[Full Text]
-
Goodridge, H. S., Marshall, F. A., Else, K. J., Houston, K. M., Egan, C., Al-Riyami, L., Liew, F.-Y., Harnett, W., Harnett, M. M.
(2005). Immunomodulation via Novel Use of TLR4 by the Filarial Nematode Phosphorylcholine-Containing Secreted Product, ES-62. J. Immunol.
174: 284-293
[Abstract]
[Full Text]
-
Drillien, R., Spehner, D., Hanau, D.
(2004). Modified vaccinia virus Ankara induces moderate activation of human dendritic cells. J. Gen. Virol.
85: 2167-2175
[Abstract]
[Full Text]
-
Boehme, K. W., Compton, T.
(2004). Innate Sensing of Viruses by Toll-Like Receptors. J. Virol.
78: 7867-7873
[Full Text]
-
Anthony, D. D., Yonkers, N. L., Post, A. B., Asaad, R., Heinzel, F. P., Lederman, M. M., Lehmann, P. V., Valdez, H.
(2004). Selective Impairments in Dendritic Cell-Associated Function Distinguish Hepatitis C Virus and HIV Infection. J. Immunol.
172: 4907-4916
[Abstract]
[Full Text]
-
Shisler, J. L., Jin, X.-L.
(2004). The Vaccinia Virus K1L Gene Product Inhibits Host NF-{kappa}B Activation by Preventing I{kappa}B{alpha} Degradation. J. Virol.
78: 3553-3560
[Abstract]
[Full Text]
-
McGettigan, J. P., Naper, K., Orenstein, J., Koser, M., McKenna, P. M., Schnell, M. J.
(2003). Functional Human Immunodeficiency Virus Type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and Env Expressed from a Single Rhabdovirus-Based Vaccine Vector Genome. J. Virol.
77: 10889-10899
[Abstract]
[Full Text]
-
Sabroe, I., Read, R. C., Whyte, M. K. B., Dockrell, D. H., Vogel, S. N., Dower, S. K.
(2003). Toll-Like Receptors in Health and Disease: Complex Questions Remain. J. Immunol.
171: 1630-1635
[Full Text]